Aspen Park Pharmaceuticals, Inc.
Pharmaceutical company · New York, United States
Aspen Park Pharmaceuticals, Inc. is a pharmaceutical company headquartered in New York, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $1.3 million sold in a notice filed in 2016.
Aspen Park Pharmaceuticals at a glance
What does Aspen Park Pharmaceuticals do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $1.3 million sold (2016).
Frequently asked questions about Aspen Park Pharmaceuticals
Where is Aspen Park Pharmaceuticals headquartered?
Aspen Park Pharmaceuticals, Inc. is headquartered in New York, United States.
What does Aspen Park Pharmaceuticals do?
Aspen Park Pharmaceuticals, Inc. is a pharmaceutical company.
When was Aspen Park Pharmaceuticals founded?
The earliest incorporation on record for Aspen Park Pharmaceuticals, Inc. is in 2014, according to public company registers.
Similar companies
- SchrodingerNew York City, New York, United States
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences